Daniel T Starczynowski, PhD
College of Medicine - UC
Daniel Starczynowski is a member of the Leukemia Research Program at the OSUCCC – James, where his research is focused on the molecular, cellular and genetic basis of hematologic malignancies.This research has uncovered the aberrant activation of the innate immune pathway in myelodysplastic syndromes (MDS) and discovered that this activation perturbs normal hematopoietic stem/progenitor (HSPC) function. Dr. Starczynowski’s broader research initiatives explore the characterization of novel candidate genes relevant to MDS, the dissection of molecular and cellular alterations in MDS, and the identification of novel therapeutics. He has co-authored more than three dozen articles appearing in well-respected publications such as Nature Medicine, Cancer Cell, Nature Immunology, The Journal of Experimental Medicine, Cell Reports, Blood and Leukemia.